MARKET
IPO

HCRX

Healthcare Royalty, Inc.
HCRX
NASDAQ
Upcoming IPOs
Expected Listing Date: - -
P/E
P/S
P/B
MARKET CAP
INDUSTRY
-
-
-
-
Investment Management & Fund Operators
2021-07-01
Public Filing
View Prospectus
Pending
Offering
Price Range: 16.00~17.00
Shares to be Issued: 46.88M
Pending
Offering End Date
Offering Price: Pending
Post IPO Outstanding: Pending
Listed
REGENXBIO announces royalty monetization agreement for up to $250M
Seeking Alpha · 05/19 20:14
About HCRX
Healthcare Royalty Inc is a United States-based mid-market royalty acquisition and investment company. The Company is focused on growth assets and companies in biopharmaceutical industry. Its portfolio is diversified across therapeutic categories, treatment modalities, indications and marketers. The assets in the Company's portfolio represents approximately 12 therapeutic categories, which includes neurology, gastroenterology, vaccines and anti-infectives, rare genetic disorder, pulmonary, oncology, hematology, immunology and endocrine.

Webull offers Healthcare Royalty, Inc. stock information, including NASDAQ: HCRX real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, HCRX stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading HCRX stock methods without spending real money on the virtual paper trading platform.